Preliminary Testing of Cafe Move for Primary Prevention of Physical Frailty

February 2, 2026 updated by: University of Montana

Cafe Move: A Novel Program for Prevention of Age-Related Physical Frailty

This project explores a novel means of health promotion and prevention of age-related physical frailty, which is designed to overcome barriers to access and promote autonomy in managing physical health.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

The purpose of this investigation is to field-test a physical function assessment paradigm, designed to inform people of their physical function relative to peers of similar demographic characteristics (e.g., similar age, sex, height, etc.), to promote recommended preventive health behaviors. The physical function assessment paradigm is known as Cafe Move. Our primary research hypothesis is that people will advance along the stages of behavior change (i.e., more likely to participate in recommended preventive healthcare for physical function), after accessing Cafe Move assessments. This study is a single cohort (n=36 participants), double-baseline design, intended primarily to collect pilot data. The results will inform the design of a larger controlled trial.

This study will examine the safety, feasibility, acceptability, and preliminary efficacy of Café Move. Briefly, we will make Café Move available to at-risk populations (i.e., independent-living older adults) via the following approach. First, during a 3-month control phase, we will monitor participants' health behaviors and engagement with preventive health offerings via periodic phone surveys. We will then make Café Move available and subsequently monitor health behaviors and engagement with preventive health offerings. This design will allow us to examine feasibility of the Café Move intervention, to better understand the reach of the program within and across communities, and to determine variance and covariance for the outcome measures of interest.

Study Type

Interventional

Enrollment (Estimated)

36

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Brian J Loyd
  • Phone Number: 406-243-4015

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

50 years to 85 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Legally autonomous to consent
  • Lives independently
  • Ability to sit, stand, and walk without the assistance of another person

Exclusion Criteria:

  • Not legally autonomous to consent
  • Institutionalized

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Health Behavior Stages of Change Questionnaire
Time Frame: through study completion, average of 4-6 months
Self-reported measure of engagement with preventive care or wellness activities
through study completion, average of 4-6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Healthcare Access and Utilization Questionnaire
Time Frame: through study completion, average of 4-6 months
Self-reported measure of healthcare utilization of a number of different services
through study completion, average of 4-6 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Two-minute walk test (2MWT)
Time Frame: through study completion, average of 4-6 months
Measure of distance walked in 2 minutes along a 50-foot course
through study completion, average of 4-6 months
Grip Strength
Time Frame: through study completion, average of 4-6 months
Measure of participants' maximum grip strength using a handheld dynamometer
through study completion, average of 4-6 months
Postural Sway
Time Frame: through study completion, average of 4-6 months
Timed test of participants' ability to balance under 4 different conditions
through study completion, average of 4-6 months
Activities-Specific Balance Confidence Scale
Time Frame: through study completion, average of 4-6 months
Self-reported questionnaire that assess participants' perceived balance
through study completion, average of 4-6 months
Lifespace Mobility Questionnaire
Time Frame: through study completion, average of 4-6 months
Self-reported questionnaire that assess participants' interaction with home and community settings
through study completion, average of 4-6 months
Role Participation Questionnaire
Time Frame: through study completion, average of 4-6 months
Self-reported questionnaire that captures various social, demographic, and activity level information from participants
through study completion, average of 4-6 months
Physical Function Questionnaire
Time Frame: through study completion, average of 4-6 months
Self-reported questionnaire assessing perceived function with daily activities
through study completion, average of 4-6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 29, 2023

Primary Completion (Estimated)

February 1, 2027

Study Completion (Estimated)

February 28, 2027

Study Registration Dates

First Submitted

January 31, 2023

First Submitted That Met QC Criteria

January 31, 2023

First Posted (Actual)

February 9, 2023

Study Record Updates

Last Update Posted (Actual)

February 5, 2026

Last Update Submitted That Met QC Criteria

February 2, 2026

Last Verified

January 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • 76-22

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Aging

Clinical Trials on Cafe Move

Subscribe